Loading...
•
Jun 30, 2024
CVRx Q2 2024 Earnings Report
CVRx's second quarter results were solid, driven by record U.S. Heart Failure business, with revenue increasing and strategic leadership appointments made.
Key Takeaways
CVRx reported a 24% increase in revenue to $11.8 million for Q2 2024, driven by a 29% increase in U.S. revenue. The company's gross profit was $9.9 million, with a gross margin of 84%. Net loss was $14.0 million, or $0.65 per share. The company strengthened its executive team to drive market development priorities.
Revenue increased by 24% to $11.8 million compared to the same period last year.
U.S. revenue increased by 29% to $10.7 million, driven by growth in the U.S. Heart Failure business.
Gross profit was $9.9 million with a gross margin of 84%.
Net loss was $14.0 million, or $0.65 per share.
CVRx
CVRx
CVRx Revenue by Segment
CVRx Revenue by Geographic Location
Revenue by Segment
U.S. Heart Failure Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comEurope Revenue
CapyFin.com Forward Guidance
The Company expects to report total revenue between $12.7 million and $13.7 million for the third quarter of 2024.